Healthcare Economist April 29, 2024
Jason Shafrin

A federal judge says ‘no’. Endpoints reports:

A New Jersey federal judge on Monday tossed cases brought by Johnson & Johnson and Bristol Myers Squibb against the Inflation Reduction Act, another victory for the law while Medicare works through the first year of price negotiations with industry.
In a summary judgment, Judge Zahid Quraishi ruled the IRA provisions don’t constitute a physical taking of property or a violation of speech, the two constitutional claims at the core of the drugmakers’ arguments. The opinion could impact similar cases playing out in other courts across the country.
“In short, Defendants are not...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Sanders: Weight loss drug could bankrupt healthcare system
Radvocates applaud bipartisan bill that would end decade-long decline in Medicare reimbursement
New Study Confirms Economic Burden of Chronic Lymphocytic Leukemia on Medicare Beneficiaries
New KFF Poll Finds that Many Older Voters Are Unaware of Medicare Drug Price Negotiation, But Awareness Has Grown
RAND Study Confirms Higher Reimbursement from Private Payers

Share This Article